Metabotropic glutamate receptors inhibit microglial glutamate release

ASN Neuro

Volumn 4, Issue 5, 2012, Pages 323-330

  McMullan, Stephen M ^a   Phanavanh, Bounleut ^a   Li, Gary Guo ^a   Barger, Steven W ^a,b,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

cAMP; G protein; Lipopolysaccharide; Microglia; Protein kinase A

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; 2 AMINO 4 PHOSPHONOBUTYRIC ACID; ADENYLATE CYCLASE; ALPHA 2 METHYL 4 SULFOPHENYLGLYCINE; AZETIDINE 2,4 DICARBOXYLIC ACID; BUCLADESINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMIC ACID; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOBUTYLMETHYLXANTHINE; LIPOPOLYSACCHARIDE; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NITRIC OXIDE; NITRITE; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; 4 (2 AMINO 6 CHLORO 9H PURIN 9 YL) 1,3 DIOXOLANE 2 METHANOL; 4-(2-AMINO-6-CHLORO-9H-PURIN-9-YL)-1,3-DIOXOLANE-2-METHANOL; AMINO ACID RECEPTOR AFFECTING AGENT; ENZYME INHIBITOR; MESSENGER RNA; METABOTROPIC RECEPTOR; PURINE DERIVATIVE;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME INHIBITION; INHIBITION KINETICS; MICROGLIA; NEGATIVE FEEDBACK; NEWBORN; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; GENETICS; GLIA; METABOLISM; SPRAGUE DAWLEY RAT;

1-METHYL-3-ISOBUTYLXANTHINE; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRAIN; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIOXOLANES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGENTS; GLUTAMIC ACID; LIPOPOLYSACCHARIDES; NEUROGLIA; NITRITES; PURINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RNA, MESSENGER;

EID: 84866696413     PISSN: 17590914     EISSN: None     Source Type: Journal    
DOI: 10.1042/AN20120044     Document Type: Article

References (43)

1. Aloisi F, De Simone R, Columba-Cabezas S, Levi G (1999) Opposite effects of interferon-gamma and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro-and anti-inflammatory activities. J Neurosci Res 56:571-580.
2. Barger SW (2004) An unconventional hypothesis of oxidation in Alzheimer's disease: intersections with excitotoxicity. Front Biosci 9:3286-3295.
3. Barger SW, Basile AS (2001) Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J Neurochem 76:846-854.
4. Barger SW, Chavis JA, Drew PD (2000) Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner. J Neurosci Res 62:503-509.
5. Barger SW, Goodwin ME, Porter MM, Beggs ML (2007) Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J Neurochem 101:1205-1213.
6. Bossuet C, Vaufrey F, Conde F, Chretien F, Pichon J, Hantraye P, Le Grand R, Dormont D, Gras G (2004) Up-regulation of glutamate concentration in the putamen and in the prefrontal cortex of asymptomatic SIVmac251-infected macaques without major brain involvement. J Neurochem 88:928-938.
7. Bridges RJ, Natale NR, Patel SA (2012) System xc(2) cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br J Pharmacol 165:20-34.
8. Byrnes KR, Loane DJ, Faden AI (2009a) Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics 6:94-107.
9. Byrnes KR, Stoica B, Loane DJ, Riccio A, Davis MI, Faden AI (2009b) Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia 57:550-560.
10. Caggiano AO, Kraig RP (1999) Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J Neurochem 72:565-575.
11. Chung DS, Traynelis SF, Murphy TJ, Conn PJ (1997) 4-Methylhomoibotenic acid activates a novel metabotropic glutamate receptor coupled to phosphoinositide hydrolysis. J Pharmacol Exp Ther 283:742-749.
12. Colton CA, Chernyshev ON (1996) Inhibition of microglial superoxide anion production by isoproterenol and dexamethasone. Neurochem Int 29:43-53.
13. Colton CA, Vitek MP, Wink DA, Xu Q, Cantillana V, Previti ML, Van Nostrand WE, Weinberg JB, Dawson H (2006) NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 103:12867-12872.
14. D'Antoni S, Berretta A, Bonaccorso CM, Bruno V, Aronica E, Nicoletti F, Catania MV (2008) Metabotropic glutamate receptors in glial cells. Neurochem Res 33:2436-2443.
15. Dello Russo C, Boullerne AI, Gavrilyuk V, Feinstein DL (2004) Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production. J Neuroinflammation 1:9.
16. Espey MG, Kustova Y, Sei Y, Basile AS (1998) Extracellular glutamate levels are chronically elevated in the brains of LP-BM5-infected mice: a mechanism of retrovirus-induced encephalopathy. J Neurochem 71:2079-2087.
17. Eun SY, Hong YH, Kim EH, Jeon H, Suh YH, Lee JE, Jo C, Jo SA, Kim J (2004) Glutamate receptor-mediated regulation of c-fos expression in cultured microglia. Biochem Biophys Res Commun 325:320-327.
18. Gochenauer GE, Robinson MB (2001) Dibutyryl-cAMP (dbcAMP) up-regulates astrocytic chloride-dependent L-[3H]glutamate transport and expression of both system xc(2) subunits. J Neurochem 78:276-286.
19. Groom AJ, Smith T, Turski L (2003) Multiple sclerosis and glutamate. Ann NY Acad Sci 993:229-275 (discussion pp. 287-228).
20. Harris ME, Wang Y, Pedigo NW, Jr., Hensley K, Butterfield DA, Carney JM (1996) Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures. J Neurochem 67:277-286.
21. Jane DE, Pittaway K, Sunter DC, Thomas NK, Watkins JC (1995) New phenylglycine derivatives with potent and selective antagonist activity at presynaptic glutamate receptors in neonatal rat spinal cord. Neuropharmacology 34:851-856.
22. Kim SY, Choi SY, Chao W, Volsky DJ (2003) Transcriptional regulation of human excitatory amino acid transporter 1 (EAAT1): cloning of the EAAT1 promoter and characterization of its basal and inducible activity in human astrocytes. J Neurochem 87:1485-1498.
23. Kobayashi T, Tsunawaki S, Seguchi H (2001) Evaluation of the process for superoxide production by NADPH oxidase in human neutrophils: evidence for cytoplasmic origin of superoxide. Redox Rep 6:27-36.
24. Korn T, Magnus T, Jung S (2005) Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-alpha. FASEB J 19:1878-1880.
25. Mascarucci P, Perego C, Terrazzino S, De Simoni MG (1998) Glutamate release in the nucleus tractus solitarius induced by peripheral lipopolysaccharide and interleukin-1 beta. Neuroscience 86:1285-1290.
26. Melendez RI, Vuthiganon J, Kalivas PW (2005) Regulation of extracellular glutamate in the prefrontal cortex: focus on the cystine glutamate exchanger and group I metabotropic glutamate receptors. J Pharmacol Exp Ther 314:139-147.
27. Mullet D, Fertel RH, Kniss D, Cox GW (1997) An increase in intracellular cyclic AMP modulates nitric oxide production in IFN-gamma-treated macrophages. J Immunol 158:897-904.
28. Noda M, Nakanishi H, Nabekura J, Akaike N (2000) AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J Neurosci 20:251-258.
29. Noda M, Kariura Y, Pannasch U, Nishikawa K, Wang L, Seike T, Ifuku M, Kosai Y, Wang B, Nolte C, Aoki S, Kettenmann H, Wada K (2007) Neuroprotective role of bradykinin because of the attenuation of proinflammatory cytokine release from activated microglia. J Neurochem 101:397-410.
30. Okado-Matsumoto A, Matsumoto A, Fujii J, Taniguchi N (2000) Effect of cAMP on inducible nitric oxide synthase gene expression: its dual and cell-specific functions. Antioxid Redox Signal 2:631-642.
31. Park YC, Park SJ, Jun CD, Kim GE, Park KI, Kim HD, Park RK, Chung HT (1997) Cyclic AMP analogue as a triggering signal for the induction of nitric oxide synthesis in murine peritoneal macrophages. Cell Immunol 179:41-47.
32. Peters-Golden M (2009) Putting on the brakes: cyclic AMP as a multipronged controller of macrophage function. Sci Signal 2:pe37.
33. Piani D, Fontana A (1994) Involvement of the cystine transport system xc-in the macrophage-induced glutamate-dependent cytotoxicity to neurons. J Immunol 152:3578-3585.
34. Pinteaux-Jones F, Sevastou IG, Fry VA, Heales S, Baker D, Pocock JM (2008) Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors. J Neurochem 106:442-454.
35. Pyo H, Jou I, Jung S, Joe E (1999) cAMP potentiates beta-amyloid-induced nitric oxide release from microglia. Neuroreport 10:37-40.
36. Rosi S, Ramirez-Amaya V, Vazdarjanova A, Esparza EE, Larkin PB, Fike JR, Wenk GL, Barnes CA (2009) Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine. Brain 132:2464-2477.
37. Sattler R, Xiong Z, Lu WY, MacDonald JF, Tymianski M (2000) Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity. J Neurosci 20:22-33.
38. Sowa G, Przewlocki R (1994) cAMP analogues and cholera toxin stimulate the accumulation of nitrite in rat peritoneal macrophage cultures. Eur J Pharmacol 266:125-129.
39. Taylor DL, Diemel LT, Pocock JM (2003) Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J Neurosci 23:2150-2160.
40. Trotti D, Danbolt NC, Volterra A (1998) Glutamate transporters are oxidantvulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci 19:328-334.
41. Wekerle H (2005) Planting and pruning in the brain: MHC antigens involved in synaptic plasticity? Proc Natl Acad Sci USA 102:3-4.
42. Willard LB, Hauss-Wegrzyniak B, Danysz W, Wenk GL (2000) The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition. Exp Brain Res 134:58-65.
43. Zhang B, Yang L, Konishi Y, Maeda N, Sakanaka M and Tanaka J (2002) Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents. Neuropharmacology 42:262-269.